Atlas Trials

A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Clinical trial NCT05255458 · COMPLETED

Trial details

NCT number
NCT05255458
Sponsor
Akeso
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2021-11-04
Primary completion
2023-01-09
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.